Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 1, 2018
Reporting Period: The filing announces financial results for the three months and the full year ended December 31, 2017.
Key Financial Metrics
The provided text serves as a cover document referencing a press release (Exhibit 99.1) for detailed financial data. The filing text itself does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached press release for specific numerical metrics.
Material Changes
The filing text does not contain specific data regarding material changes versus prior periods. It only confirms the issuance of results for the period ended December 31, 2017.
Guidance, Outlook, and Management Commentary
Management Action: On March 1, 2018, the company issued a press release and scheduled a conference call for 4:30 PM EST to discuss the results.
Legal Disclaimer: The information in Item 2.02 and the attached press release is furnished but not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section, nor is it incorporated by reference in other filings unless expressly stated.
Important Facts for Investor Verification
- Verify the specific revenue and net income figures in the attached Press Release (Exhibit 99.1), as they are not listed in the 8-K body.
- Confirm the details of the conference call held on March 1, 2018, for management commentary on the 2017 performance.
- Note that the financial data in this filing is not legally "filed" for liability purposes under Section 18 of the Exchange Act.
- Check the company's status as an emerging growth company (indicated as unchecked in the filing).